Vimarsana
Biggest News Aggregation in the World

Page 46 - Heca News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Heca. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Heca Today - Breaking & Trending Today

Philips to pay $62 mln to resolve charges it violated US law, SEC says - Vimarsana News

Philips to pay $62 mln to resolve charges it violated US law, SEC says

Dutch medical device maker Philips will pay more than $62 million to resolve charges that it violated the Foreign Corrupt Practices Act over its conduct related to sales of medical equipment to China, the U.S. Securities and Exchange Commission said on Thursday.

Exclusive: Wegovy, other weight loss drugs 'no silver bullet', says WHO amid obesity review - Vimarsana News

Exclusive: Wegovy, other weight loss drugs 'no silver bullet', says WHO amid obesity review

New highly-effective weight loss drugs such as Novo Nordisk's Wegovy are not a “silver bullet” for addressing the rapid rise in global obesity rates, the World Health Organization’s nutrition chief told Reuters, as the agency conducts its first review of obesity management guidelines in more than 20 years.

GSK sells $1 bln discounted stake in spin-off Haleon - Vimarsana News

GSK sells $1 bln discounted stake in spin-off Haleon

British drugmaker GSK on Friday sold 240 million shares in its consumer healthcare business Haleon at 335 pence per share, raising about 804 million pounds ($1 billion), the company said.

Gaza cancer patients miss treatment as Israel border shut amid fighting - Vimarsana News

Gaza cancer patients miss treatment as Israel border shut amid fighting

Gaza resident Dina El-Dhani was due to meet her oncologist this week at a hospital in Jerusalem but she has been unable to cross into Israel since the border was closed amid heavy fighting between Israel and Palestinian militants.

Japan's Otsuka Pharma gets FDA approval for Alzheimer's agitation drug - Vimarsana News

Japan's Otsuka Pharma gets FDA approval for Alzheimer's agitation drug

The U.S. Food and Drug Administration approved Otsuka Pharmaceutical's brexpiprazole to treat agitation in patients with Alzheimer's on Thursday, making it the first approved drug for the indication, the company said in a statement.